Pharmaceuticals, Biotechnology and Life Sciences
PRIME (PRIority MEdicines) designation based on clinical study results evaluating safety and efficacy of novel CAR-T therapy in the treatment…
First DARZALEX combination regimen being pursued as frontline treatment option for transplant eligible patients with multiple myeloma BEERSE, Belgium–(BUSINESS WIRE)–The…
Application supported by the Phase 3 MAIA study for daratumumab in combination with lenalidomide and dexamethasone for the treatment of…
Novartis has had Cosentyx compared against Janssen’s IL-23 Stelara, and it showed superior improvements for psoriasis patients, it said in a statement Tuesday, noting that it was processed and transmitted by West Corporation.
U.S. Food and Drug Administration (FDA) approved AbbVie’s Imruvica (ibrutinib) combined rituximab (Rituxan) for treating adult patients with Waldenström’s macroglobulinemia (WM).
Johnson & Johnson’s Janssen has welcomed the news from Health Canada as it got approval to use Zytiga combined with prednisone…
The U.S. Food and Drug Administration has approved Janssen Pharmaceutical ‘sErleada (apalutamide) for the treatment of patients with prostate cancer that has…
Idorsia Ltd has made meaningful collaboration with industry leaders in the six and a half months since the demerger from…
Idorsia said Monday Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has exercised its option to enter…
Janssen has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for darunavir several doses, for…